Start

Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia

Purpose:

To determine if a patient with cancer and chronic anemia is likely to respond to erythropoietin (EPO) therapy.

Specialty:

Hematology, Gynecological Oncology, Hematology/Oncology, Medical Oncology, Pediatric Hematology/Oncology, Hematology

Objective:

administration, response to therapy, adverse effects, drug levels

ICD-10:

C00-D49, D55-D59, D60-D64, D63

Description:

Patients with anemia may develop a chronic anemia that impacts the quality of life, and some of these patients may benefit from administration of recombinant erythropoietin. Ludwig et al identified factors indicating the likelihood of response to erythropoietin administration. The authors are from Vienna and Graz in Austria.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone